| Literature DB >> 33036216 |
Turksen Shilts1, Choaa El-Mohtar1, William O Dawson1, Nabil Killiny1.
Abstract
Plant viruses are threatening many valuable crops, and Citrus tristeza virus (CTV) is considered one of the most economically important plant viruses. CTV has destroyed millions of citrus trees in many regions of the world. Consequently, understanding of the transmission mechanism of CTV by its main vector, the brown citrus aphid, Aphis (Toxoptera) citricidus (Kirkaldy), may lead to better control strategies for CTV. The objective of this study was to understand the CTV-vector relationship by exploring the influence of viral genetic diversity on virus transmission. We built several infectious clones with different 5'-proximal ends from different CTV strains and assessed their transmission by the brown citrus aphid. Replacement of the 5'- end of the T36 isolate with that of the T30 strain (poorly transmitted) did not increase the transmission rate of T36, whereas replacement with that of the T68-1 isolate (highly transmitted) increased the transmission rate of T36 from 1.5 to 23%. Finally, substitution of p33 gene of the T36 strain with that of T68 increased the transmission rate from 1.5% to 17.8%. Although the underlying mechanisms that regulate the CTV transmission process by aphids have been explored in many ways, the roles of specific viral proteins are still not explicit. Our findings will improve our understanding of the transmission mechanisms of CTV by its aphid vector and may lead to the development of control strategies that interfere with its transmission by vector.Entities:
Keywords: Aphis (Toxoptera) citricidus (Kirkaldy); Citrus tristeza virus; P33 protein; aphid transmission; virus recombinant; virus–vector interaction
Mesh:
Substances:
Year: 2020 PMID: 33036216 PMCID: PMC7600554 DOI: 10.3390/v12101131
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
List of primers used in building CTV infectious hybrid clones.
| Primer | Orientation | Restriction Enzyme | Sequence 5′—3′ |
|---|---|---|---|
| C1882 | Reverse | CCCGCACTTGCGGGGAGAAACCGTACG | |
| C2267 | Forward | * ApaI | GTT |
| C2268 | Forward | - | AATTTCGATTCAAATTCACCCGTATCTCCGGAGCTCGAT |
| C2275 | Forward | - | CTGAACGTGGGAAGATTGGGGATTTCAGTTTTCCGAGT |
| C2276 | Reverse | - | ACTCGGAAAACTGAAATCCCCAATCTTCCCACGTTCAG |
| C2277 | Forward | - | TCCTAGTCATCACTCGAGTGCCGCTCGTGGGCAACGTT |
| C2278 | Forward | - | TCAGTTTTTCGCGATTTTTGTACGATTCGCGTTA |
| C2279 | Forward | - | CCCGTCGCACGTGACATAACGTACAAGAAGATGACCAA |
| C2280 | Reverse | - | AGACTATGCTCCGAATTAGTGAACGTCAAATCTTT |
| C2281 | Reverse | - | ATAGCCACCGTCGAAAACGTGGTACCAAAGTCTA |
| C2296 | Forward | - | AAGGTATAATTCGAGGAAGTCCTTCTATACGCG T |
| C2298 | Reverse | - | ACTCGGAGGGCCAGCCGAACGACGACTAACACCG |
| C2299 | Forward | - | GTT GAA GGC TGT GGG TTT CGA CAG GAA GTT AAC C |
| C2300 | Reverse | - | ACAGGATACTTTAGTACAGTAGTCGGAAAAGTACTTC |
| C2302 | Reverse | - | ACCAAAGTCTAGACCCAGAAGCACCATACCGCT |
| C2331 | Reverse | Bsu36I | AGTT |
| C2332 | Forward | Bsu36I | GTA |
| C2348 | Forward | - | TGAATGCTAAGACTTTTGAATGGACTTGGAA |
| C2352 | Forward | - | ACGTAGGTGGTTGCCCATTATTTCATTTACGTAAGTTTCTGCTTCTACCTTTGA |
| C2353 | Reverse | - | TCAAAGGTAGAAGCAGAAACTTACGTAAATGAAATAATGGGCAACCACCTACGT |
| C2354 | Forward | - | ATATATGACCAAAATTTGTTGATGTGCAGGTGCGGGTCATACAGGAGTTCACGTTTGCA |
| C2355 | Reverse | - | TGCAAACGTGAACTCCTGTATGACCCGCACCTGCACATCAACAAATTTTGGTCATATAT |
| C2356 | Forward | Bsu36I | CATA |
| C2357 | Reverse | Bsu36I | GTT |
| C-2358 | Reverse | XmaI | GGA |
| C2470 | Reverse | PacI | ACC |
| C2475 | Forward | StuI | AAT |
Restriction sites within the primers are underlines. * Restriction site was added to the primer sequence.
Figure 1Schematic representation describing the cloning steps of the Citrus tristeza virus (CTV) T30-T36 (35s230-37) infectious hybrid clone. (A) The 35s201I plasmid vector of VT-T36 was used as a backbone clone; (B) the fragment containing the helicase, RdRP, and p33 was amplified from strain T30, and ligated into plasmid vector 35s201I, which was digested with restricted enzymes XmaI and PmeI; (C) the fragment containing leader protease LP2 to helicase from T30 was amplified and ligated into the plasmid vector after digesting with Bsu361 and XmaI; (D) the fragment covering nucleotides 182 to 4431 from the T30 strain was amplified and ligated into the vector after digestion with AscI and Bsu36I restriction enzymes; (E) the fragment containing the AscI restriction enzyme site until the 182 nt was amplified and added to the plasmid vector digested with ApaI and AscI restriction enzymes to produce the new infectious hybrid clone named 35s230-37 used for studying the transmission of CTV.
Figure 2Schematic representation of cloning steps of the CTV T36-T68 (35s200) infectious hybrid clone. (A) The 35s193 plasmid vector of VT-T36 which was used as a backbone clone; (B) the fragment containing helicase, RdRP, and p33 was amplified from isolate T68-1 and ligated into the CTV-T36 infectious plasmid vector 35s193, which was digested with the same restriction enzymes (XmaI and PmeI); (C) the fragment between leader protease LP2 and helicase from T68-1 was amplified and ligated into the plasmid vector after digesting with PspXI and XmaI; and (D) the fragment flanking the ApaI restriction enzyme site at the 35s (CaMV) promoter and a PspXI restriction enzyme site at nucleotide 2068 was added to the plasmid vector to produce the new infectious hybrid clone named 35s200 used for studying the transmission of CTV.
Figure 3Schematic representation of cloning steps of the 35sT8 infectious hybrid created to isolate the p33 gene from the T68 strain. (A) The 35s200 hybrid used for amplification of the p33 gene of T68. (B) Hybrid 35s246 is an infectious cDNA clone of the T36 strain of CTV containing a gfp replacement of the p33 gene. (C) The 35s246 hybrid was digested with restriction enzymes StuI and PacI, and the gfp was replaced with the amplified p33 gene from 35s200 to produce the new infectious hybrid clone named 35sT8.
ELISA result of source plants used for aphid transmission of CTV.
| Isolates/Hybrids | O.D. @ 405 nm * |
|---|---|
| Control | 0.25 ± 0.10 a |
| T36 | 3.41 ± 0.05 b |
| WT-T68 | 3.50 ± 0.04 b |
| WT-T30 | 3.02 ± 0.20 b |
| 35s230-37 (CTV T36/T30) | 3.19 ± 0.20 b |
| 35s200 (CTV T36/T68) | 3.40 ± 0.10 b |
| 35sT8 (CTV T36/T68-P33) | 3.36 ± 0.02 b |
* Different letters indicate statistically significant differences (p < 0.05). Statistical analysis was performed using ANOVA followed by post hoc pairwise comparison (Tukey). Five plants were used for each isolate or infectious clone.
Figure 4Aphid transmission of CTV strains and constructed hybrids. (A) Schematic representation of the genome of the parent CTV isolates (T68-1, T30, and T36 infectious clone) used to construct the hybrids. (B) Schematic representation of the infectious hybrid clones (35s230-37, 35s200, and 35sT8) showing the replaced genes. (C) Transmission rates of the parent isolates and the constructed infectious hybrids by A. citricidus. Genes from T36 are colored in orange, genes from T68-1 are colored in blue, and genes from T30 are colored in yellow. Treatments with different letters on bars indicate statistically different transmission rates (p < 0.05).